ADMISSION'17

ARE YOU READY TO APPLY?

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et
dolore magna aliquaenim ad minim veniam

WELCOME TO

EDUCON UNIVERSITY

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et.dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Notice Board

October 17, 2017

Veričina priča

October 17, 2017

Vladanova priča

October 17, 2017

Saletova priča

Upcoming Event

scholarships information

Detailed information, brochures and forms can be mailed to you upon request.
Lorem ipsum dolor sit amet, consectetur adipi sicing elit, sed do eiusmod tempor incididunt ut labore et.dolore magna aliquauis aute irure dolor.

FEATURED COURSES

Lorem ipsum dolor sit amet, consectetur adipiscing aelit, sed do eiusmod tempor incididunt.

science

Electrical Engineering

Lorem ipsum dolor sit amet, consetetur adipiscing elitsed do eius

Apply Now
science

Chemical Engineering

Lorem ipsum dolor sit amet, consetetur adipiscing elitsed do eius

Apply Now
science

Actuarial Science

Lorem ipsum dolor sit amet, consetetur adipiscing elitsed do eius

Apply Now

LATEST NEWS

Lorem ipsum dolor sit amet, consectetur adipiscing aelit, sed do eiusmod tempor incididunt.

October 22, 2018 maja

Evaluating the risk of developing acute myeloid leukemia or myelodysplastic syndrome after a stem cell transplant

Evaluating the risk of developing acute myeloid leukemia or myelodysplastic syndrome

Read More 0
October 22, 2018 maja

Hodgkin Lymphoma Above and Below the Diaphragm: Are The Outcomes Different?

Hodgkin Lymphoma Above and Below the Diaphragm: Are The Outcomes Different? This

Read More 0
October 22, 2018 maja

Chlorambucil, rituximab and lenalidomide combination treatment for patients with chronic lymphocytic leukemia

Chlorambucil, rituximab and lenalidomide combination treatment for patients with

Read More 0